SPONSOR
Institut du Cancer de Montpellier - Val d'Aurelle
Total Trials
8
Recruiting
8
Phases
N/A
Conditions studied: Cancer SurvivorsPeripheral Neuropathic PainCarcinoma, Ovarian EpithelialFallopian Tube NeoplasmsPeritoneal NeoplasmsThyroid CancerProstate CancerNeuroendocrine TumorsColon CancerRectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Cancer Survivors, Peripheral Neuropathic Pain, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut du Cancer de Montpellier - Val d'Aurelle
How many clinical trials has Institut du Cancer de Montpellier - Val d'Aurelle sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Institut du Cancer de Montpellier - Val d'Aurelle, of which 8 are actively recruiting participants. These trials cover conditions including Cancer Survivors, Peripheral Neuropathic Pain, Carcinoma, Ovarian Epithelial. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut du Cancer de Montpellier - Val d'Aurelle research focus on?
Institut du Cancer de Montpellier - Val d'Aurelle clinical trials span Cancer Survivors, Peripheral Neuropathic Pain, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Institut du Cancer de Montpellier - Val d'Aurelle clinical trial?
To participate in a Institut du Cancer de Montpellier - Val d'Aurelle trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut du Cancer de Montpellier - Val d'Aurelle trials with current recruitment status updated daily.
Clinical Trials by Institut du Cancer de Montpellier - Val d'Aurelle
NCT06834685
Recruiting
Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients
Cancer Survivors
NCT03976999
Recruiting
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
Carcinoma, Ovarian Epithelial
NCT04104529
Recruiting
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
Thyroid Cancer
NCT05257135
Recruiting
A Clinico-biological Database in Cachexia in Patients With Colon Cancer
Colon Cancer
NCT07098182
Recruiting
Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)
Rectal Cancer
NCT04224064
Recruiting
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
Liposarcoma
NCT04458792
Recruiting
Establishment of a Prospective Clinical-biological Database
Sarcoma
NCT05056350
Recruiting
Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology